Releases & Statements Archives - Page 15 of 19 - SCPC

Dec 12, 2017

New SCPC Comments to FTC Detail Steps to Foster Competition in Pharmaceutical Pricing and Supply Chain

2017 Year-End Focus on Drug Pricing by Senate HELP, House Energy and Commerce Committees Demonstrate Ongoing Saliency of Examining PBM Market Manipulation…Read More.

Nov 28, 2017

National LTC Pharmacy Group Praises Proposed CMS Rule for Recognizing PBM Abuses, Proposing Ways to Stop Them

SCPC Also Lauds Implementation of 2016 CARA Bill Recognizing Essential Difference Between LTC and Retail Pharmacies…Read More.

Nov 16, 2017

National Pharmaceutical Council (NPC) Survey Spotlights PBM Credibility, Trust Deficit

Just One-Third of Employers Rate Their PBM as “Very Trustworthy”…Read More.

Nov 14, 2017

Nation’s Independent Long Term Care Pharmacies Commend Administration for Nomination of Alex Azar II for Secretary of the U.S. Department of Health and Human Services (HHS)

SCPC today commended President Trump for his nomination of Alex Azar for Secretary of the Department of Health and Human Services (HHS)…Read More.

Oct 27, 2017

CVS-Aetna Merger Proposal Emblematic of Growing Arms Race to Consolidate, Control Consumer Access to Health Care, Prescription Drugs

In Wake of HELP Hearing on Rising Drug Prices, Merger Plan Criticized as Anti-Consumer Shell Game…Read More.

Oct 20, 2017

New Anthem PBM Serviced by CVS Perpetuates Oligopolistic, Anti-Consumer Shell Game

Commenting on health insurer Anthem’s announcement that it will launch its own “in house” pharmacy benefit manager (PBM) to be managed by CVS Health Corp., the Senior Care Pharmacy Coalition (SCPC) said the development represents a perpetuation of the oligopolistic, anti-consumer shell game…Read More.

Oct 17, 2017

Solutions to PBM Pricing Abuses Must Address Entire Drug Supply Chain

SCPC Tells HELP Committee “A comprehensive full-spectrum solution is the only real option”…Read More.

Oct 16, 2017

Another New Study Details Pharmacy Benefit Manager (PBM) Pocketing Rebates as Profits — Not Passing on to Patients Through Lower Premiums

Another new study undermines Pharmacy Benefit Managers’ (PBMs) empty claims that “rebates” they negotiate with drug makers are actually passed along to consumers…Read More.

Oct 3, 2017

SCPC: New Study of Medicare “DIR” Fee Legislation Helps Demonstrate PBMs as Bad Actors Across Full Spectrum of Transactions

Solutions to PBM Pricing Abuses Must Address Entire Drug Supply Chain…Read More.

Releases & Statements